Bedminster, NJ, United States of America

Amol Singh Matharu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Sandoz Gmbh. Active years: 2011.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amol Singh Matharu: Innovator in Extended-Release Antibiotic Composition

Introduction

Amol Singh Matharu is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compositions. His innovative work has led to the creation of a unique extended-release antibiotic formulation.

Latest Patents

Amol Singh Matharu holds a patent for an extended-release antibiotic composition. This composition comprises at least one antibiotic and greater than 50 weight percent of a polymer component. The polymer component includes at least one pharmaceutically acceptable hydrophilic polymer and has a viscosity of less than about 50 cps. This invention aims to enhance the effectiveness and delivery of antibiotics in medical treatments.

Career Highlights

Amol is currently employed at Sandoz GmbH, a global leader in generic pharmaceuticals. His role at the company allows him to apply his expertise in pharmaceutical formulations and contribute to the development of innovative healthcare solutions.

Collaborations

Throughout his career, Amol has collaborated with esteemed colleagues, including Mahendra R Patel and Bhaskarbhai C Patel. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical industry.

Conclusion

Amol Singh Matharu's contributions to the field of antibiotic compositions exemplify the importance of innovation in healthcare. His work not only advances pharmaceutical science but also enhances patient care through improved medication delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…